---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-025724"
form_type: "8-K"
ticker: "ENVB"
cik: "0000890821"
company_name: "Enveric Biosciences, Inc."
filed_at: "2022-09-13T23:59:59+00:00"
generated_at: "2026-06-23T10:33:56.265869+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Enveric Biosciences appoints Robert Dickey IV as interim CFO effective Sept 9, 2022

## Summary
- Robert Dickey IV, age 66, appointed as interim CFO effective September 9, 2022.
- Mr. Dickey is Managing Director at Foresite Advisors, providing finance support for life science companies.
- Previously served as CFO of Motif Bio Plc (2017-2018) and Tyme Technologies (2015-2017).
- He holds an MBA from Wharton and a BA from Princeton.

## SEC filing metadata
- accession: 0001493152-22-025724
- form_type: 8-K
- ticker: ENVB
- cik: 0000890821
- company_name: Enveric Biosciences, Inc.
- filed_at: 2022-09-13T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/890821/000149315222025724/0001493152-22-025724-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/890821/000149315222025724/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-025724
- JSON: https://secwatch.observer/filing/0001493152-22-025724.json
- Plain text: https://secwatch.observer/filing/0001493152-22-025724.txt

## Key facts
- Executive change
  Robert Dickey IV was appointed as Chief Financial Officer at Enveric Biosciences, Inc..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: On September 9, 2022, Robert Dickey IV was appointed as the Chief Financial Officer (“CFO”) of the Company, to serve on an interim basis, effective September 9, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/890821/000149315222025724/0001493152-22-025724-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.